| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $807.3M | — | +33.7% |
| Cost of Revenue | $330.1M | — | +38.7% |
| Gross Profit | $477.3M | — | +30.5% |
| R&D Expense | $188.9M | — | +25.1% |
| SG&A Expense | $259.1M | — | +15.9% |
| Operating Income | $29.2M | — | +432.6% |
| Pre-tax Income | $200.2M | — | +84.7% |
| Income Tax | $30.9M | — | +51.4% |
| Net Income | $169.3M | — | +92.4% |
| EPS (Basic) | $2.11 | — | +85.1% |
| EPS (Diluted) | $2.05 | — | +89.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $458.9M | -61.8% | -58.0% |
| Short-term Investments | $260.0M | -48.6% | -76.3% |
| Inventory | $408.0M | +19.4% | +45.9% |
| Current Assets | $2.74B | -26.1% | -27.3% |
| Total Assets | $7.07B | +1.0% | +16.2% |
| Current Liabilities | $1.21B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$31.5M | — | -222.2% |
| Capital Expenditures | $23.1M | — | -7.0% |
| Investing Cash Flow | -$616.9M | — | +12.1% |
| Financing Cash Flow | -$92.3M | — | -107.0% |
| Free Cash Flow | -$54.6M | — | -5962.9% |
| -9.6% |
| Long-term Debt | $1.73B | -4.4% | -13.7% |
| Total Liabilities | $3.53B | -6.0% | +0.2% |
| Stockholders' Equity | $3.53B | +9.0% | +38.3% |